Why the study?
The process, monitoring, and dose titration of clozapine rechallenge are inconsistently reported in the literature following myocarditis.
Does clozapine rechallenge result in successful treatment in patients with prior clozapine-associated myocarditis?
Does clozapine rechallenge result in successful treatment in patients with prior clozapine-associated myocarditis?
Clozapine rechallenge after clozapine-associated myocarditis appears successful in a majority of reported cases, though data quality is limited by reliance on case reports.
Answers are grounded in this paper and cite their sources.
May support monitored rechallenge in select cases; hypothesis-generating pending prospective trials.
The process, monitoring, and dose titration of clozapine rechallenge are inconsistently reported in the literature. Despite this, 69% of case reports detailed a successful rechallenge post CAM; noting limitations associated with reliance on case data. Ensuring published clozapine rechallenge cases report standardised data, including titration speed and monitoring frequencies, is required to guide the development and validation of guidelines for clozapine rechallenge.
No takes yet. Share an insight, caveat, or question.
McMahon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: